Atrial Fibrillation

Traumatic Life Events May Increase Risk for Atrial Fibrillation in Older Women

Traumatic Life Events May Increase Risk for Atrial Fibrillation in Older Women

By

There may be a relationship between traumatic life event stress and atrial fibrillation in women over the age of 45 years old.

Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke

Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke

By

Investigators observed a significant association between atrial fibrillation and increasing oxygen desaturation index.

Atrial Fibrillation Tied to Higher Dementia Risk in Older Adults

Atrial Fibrillation Tied to Higher Dementia Risk in Older Adults

Atrial fibrillation is associated with a faster global cognitive decline and an increased risk for dementia in older people, though anticoagulants may reduce dementia risk in AF patients.

Genetic Predisposition to Early-Onset AF Noted Across Racial and Ethnic Groups

Genetic Predisposition to Early-Onset AF Noted Across Racial and Ethnic Groups

Probands of African or Hispanic/Latino descent with early-onset atrial fibrillation are more likely than European Americans to have a first-degree relative with AF

Variations in Published Stroke Rates Confound Net Anticoagulation Benefit Analyses

Variations in Published Stroke Rates Confound Net Anticoagulation Benefit Analyses

By

Variations in published stroke rates for patients with AF not receiving anticoagulants result in differences in the calculated net clinical benefit of anticoagulation.

Net Clinical Benefits of Anticoagulants for AF Vary With Stroke Rate

Net Clinical Benefits of Anticoagulants for AF Vary With Stroke Rate

There is variation in the net clinical benefit of anticoagulants based on variation in published atrial fibrillation stroke rates.

Effect of Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators

Effect of Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators

For high-risk patients with implantable cardioverter-defibrillators, ranolazine does not significantly reduce the risk of ventricular tachycardia, or ventricular fibrillation.

New Apple Watch Includes Irregular Heart Rhythm Notification Feature

New Apple Watch Includes Irregular Heart Rhythm Notification Feature

By

The irregular rhythm notification feature analyzes pulse rate data to identify episodes of irregular heart rhythms.

VKA vs Non-VKA Oral Anticoagulants: Mortality Rates Compared in AF

VKA vs Non-VKA Oral Anticoagulants: Mortality Rates Compared in AF

By

The new analysis included 19,134 of these patients and showed that there were 19% fewer deaths in patients initiated on NOACs compared to VKAs at the time of AF diagnosis.

CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation

CHEST Releases Guideline for Antithrombotic Therapy in Atrial Fibrillation

By

Patients with atrial fibrillation who have ≥1 non-sex CHA2DS2VASc stroke risk factor should receive oral anticoagulation as antithrombotic therapy.

CHA<sub>2</sub>DS<sub>2</sub>-VASc Scores Drive Clinical Outcomes in Atrial Fibrillation, Flutter

CHA2DS2-VASc Scores Drive Clinical Outcomes in Atrial Fibrillation, Flutter

By

Clinical outcomes in atrial fibrillation vs atrial flutter differ in terms of ischemic stroke, heart failure hospitalizations, and all-cause mortality.

Active EKG monitoring screening leads to earlier diagnosis and treatment for atrial fibrillation compared with delayed monitoring

In this randomized controlled trial, patients who received immediate atrial fibrillation monitoring with a new, wearable EKG were more likely to have their AF diagnosed compared with the delayed monitoring group. Patients in the active monitoring group also had a higher rate of initiation of anticoagulation therapy.

Perspectives on USPSTF Afib Screening Recommendation

Perspectives on USPSTF Afib Screening Recommendation

Physicians responded to the USPSTF's recommendation citing insufficient evidence to assess the benefits and harms of atrial fibrillation screening in asymptomatic, older adults.

USPSTF Does Not Recommend Afib Screening in Asymptomatic Patients

USPSTF Does Not Recommend Afib Screening in Asymptomatic Patients

US Preventive Services Task Force says benefit of screening for atrial fibrillation is unclear in asymptomatic, older patients.

Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib

Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib

By

Patients with atrial fibrillation who take NSAIDs in addition to oral anticoagulants may have an increased risk for major bleeding and stroke.

Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation

Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation

By

Patients with higher levels of thyroid-stimulating hormone were more likely to experience atrial tachyarrhythmia after catheter ablation for atrial fibrillation.

Atrial Fibrillation Development Predicted by Sleep Disruption

Atrial Fibrillation Development Predicted by Sleep Disruption

By

Individuals with more frequent nighttime awakening exhibited a higher risk for atrial fibrillation.

Asthma and Poorly Controlled Asthma May Increase Atrial Fibrillation Risk

Asthma and Poorly Controlled Asthma May Increase Atrial Fibrillation Risk

By

Individuals with clinician-diagnosed asthma were at an estimated 38% higher risk for atrial fibrillation.

Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease

Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease

By

Apixaban demonstrated superiority over warfarin in terms of reducing the risk for major bleeding in patients with atrial fibrillation and end-stage kidney disease who were on dialysis.

High-Risk Atrial Fibrillation Diagnosis Facilitated by Home-Based ECG

High-Risk Atrial Fibrillation Diagnosis Facilitated by Home-Based ECG

By

Using a continuous ECG monitoring patch at home in patients at high risk for atrial fibrillation resulted in higher diagnosis rates, more anticoagulation initiation, and increased healthcare resource utilization.

Apixaban Is Safest Direct Oral Anticoagulant vs Warfarin

Apixaban Is Safest Direct Oral Anticoagulant vs Warfarin

Apixaban reduced risks of major, intracranial, and gastrointestinal bleeding compared with warfarin.

Weight Loss Linked to Reversal of Atrial Fibrillation Progression

Weight Loss Linked to Reversal of Atrial Fibrillation Progression

Increased weight loss with risk factor management associated with greater atrial fibrillation freedom.

Variation in Quality of Trials for Atrial Fibrillation, Flutter

Variation in Quality of Trials for Atrial Fibrillation, Flutter

Most common trial end point is atrial fibrillation or atrial flutter recurrence; rates of primary clinical end points are low.

Atrial Fibrillation Risk Linked to Sleep Disruption

Atrial Fibrillation Risk Linked to Sleep Disruption

Higher risk for atrial fibrillation seen across multiple cohorts, regardless of obstructive sleep apnea and other possible factors.

Troponin-T, NT-proBNP May Predict Mortality Risk in Atrial Fibrillation

Troponin-T, NT-proBNP May Predict Mortality Risk in Atrial Fibrillation

By

Troponin-T, N-terminal pro-B-type natriuretic peptide, and growth differentiation factor-15 may offer prognostic utility on mortality and bleeding events in patients with atrial fibrillation who receive anticoagulation.

Rivaroxaban Use in Older Patients: Does Age Influence Safety, Efficacy?

Rivaroxaban Use in Older Patients: Does Age Influence Safety, Efficacy?

By

Data from large Phase 3 studies showed that treatment with rivaroxaban was found to be safe and effective in older patients.

Work Stress May Increase Risk of Developing Atrial Fibrillation

Work Stress May Increase Risk of Developing Atrial Fibrillation

Job strain linked with increased risk for incident atrial fibrillation.

New Coagulation Monitoring Device Allows for Wireless Reporting of INR Results

New Coagulation Monitoring Device Allows for Wireless Reporting of INR Results

By

The system is intended for properly selected trained users ≥22 years of age who have been stabilized on anticoagulation with vitamin K antagonists for ≥6 weeks.

Stroke Risk Highest in Paroxysmal Afib With Greater Burden of Afib

Stroke Risk Highest in Paroxysmal Afib With Greater Burden of Afib

By

A greater burden of atrial fibrillation or flutter in patients with paroxysmal atrial fibrillation was associated with a higher risk for stroke when not taking anticoagulants.

COPD May Increase the Risk for Atrial Fibrillation

COPD May Increase the Risk for Atrial Fibrillation

By

Patients with COPD had a nearly 2-fold increased risk for developing atrial fibrillation compared with patients without COPD.

Sign Up for Free e-Newsletters